6-K
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2009
Commission File Number 1-14840
AMDOCS LIMITED
Suite 5, Tower Hill House Le Bordage
St. Peter Port, Island of Guernsey, GY1 3QT Channel Islands
Amdocs, Inc.
1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
FORM 20-F þ      FORM 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to rule 12g3-2(b) under the Securities Exchange Act of 1934.
YES o      NO þ
 
 

 


TABLE OF CONTENTS

SIGNATURES
EXHIBIT INDEX
EX-99.1


Table of Contents

     On April 22, 2009, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended March 31, 2009. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.
     The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 


Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  AMDOCS LIMITED
 
 
  /s/  Thomas G. O’Brien  
  Thomas G. O’Brien  
  Treasurer and Secretary
Authorized U.S. Representative 
 
 
Date:  April 22, 2009

 


Table of Contents

EXHIBIT INDEX
     
EXHIBIT NO.   DESCRIPTION
 
   
99.1
  Amdocs Limited Press Release dated April 22, 2009.

 

EX-99.1
     
PRESS RELEASE   (AMDOCS LOGO)
Amdocs Limited Reports Quarterly Revenue of $711 Million
Key highlights:
    Second quarter revenue of $711 million, in-line with guidance of $700-$720 million
 
    Second quarter non-GAAP operating income of $128 million; non-GAAP operating margin of 18.0%; GAAP operating income of $96 million
 
    Second quarter diluted non-GAAP EPS of $0.50, excluding acquisition-related costs and equity-based compensation expense, net of related tax effects, in-line with guidance
 
    Diluted GAAP EPS of $0.39 for the quarter
 
    Free cash flow of $62 million for the quarter; included in the calculation of second quarter free cash flow was $52 million in annual employee bonus payments
 
    12-month backlog of $2.37 billion at the end of the second quarter
 
    Third quarter fiscal 2009 guidance: Expected revenue of approximately $670-$690 million and diluted non-GAAP EPS of $0.46-$0.50, excluding acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.33-$0.38
St. Louis, MO – April 22, 2009 – Amdocs Limited (NYSE: DOX) today reported that for its fiscal second quarter ended March 31, 2009, revenue was $711.1 million, a decrease of 8.2% from last year’s second quarter. Net income on a non-GAAP basis was $104.9 million, or $0.50 per diluted share, compared to non-GAAP net income of $126.6 million, or $0.58 per diluted share, in the second quarter of fiscal 2008. Non-GAAP net income excludes amortization of purchased intangible assets and equity-based compensation expenses of $24.2 million, net of related tax effects, in the second quarter of fiscal 2009 and excludes such amortization and equity-based compensation expenses of $26.8 million, net of related tax effects, in the second quarter of fiscal 2008. The Company’s GAAP net income for the second quarter of fiscal 2009 was $80.6 million, or $0.39 per diluted share, compared to

 


 

GAAP net income of $99.9 million, or $0.46 per diluted share, in the prior year’s second quarter.
“In the second quarter of fiscal 2009 difficult economic conditions continued to impact our customers’ buying decisions. Sales cycles remained extended, particularly for larger, transformational projects, and certain customers delayed commitments for new projects. We had anticipated operating in a difficult environment during the quarter and are pleased with our execution in sales, cost control and cash collections. Our second quarter revenue of $711 million and diluted non-GAAP earnings per share of $0.50 were in-line with our guidance, and we delivered on our 18% non-GAAP operating margin target for the quarter,” said Dov Baharav, chief executive officer of Amdocs Management Limited.
Baharav continued, “For the third quarter of fiscal 2009, Amdocs expects that revenue will be approximately $670-$690 million as we anticipate on-going weakness in the economic environment. We are managing our expenses under the assumption that revenue for the year could be down 10%-12% relative to fiscal year 2008, with foreign currency effects contributing roughly 3% of the decline. While we cannot yet provide a precise range for our fourth quarter revenue expectations, at this time we believe that fourth quarter revenue is likely to decline sequentially from third quarter levels.”
Baharav concluded, “While these are difficult times for our industry and for Amdocs, we signed a number of important deals in the second quarter which position us well with some key customers. We are managing expenses to protect profitability and cash flow and we are investing in our future, including in R&D, so that we can continue to provide the best products and services to our industry. We believe we are well-positioned for growth when economic conditions improve.”
In the second quarter Amdocs won new business with existing customers and new logos. These wins include new business in each of Amdocs’ four focus areas for growth: cable/satellite, managed services, emerging markets and OSS, including the examples below.
Cable/satellite

 


 

    Amdocs signed a transformational BSS project based on the CES 7.5 portfolio with a major satellite provider in Asia-Pacific spanning billing, ordering, CRM, self-service and partner relationship management.
Managed Services
    Clearwire selected Amdocs for a multi-year agreement for the license and implementation of Amdocs CES 7.5 products and managed services to support Clearwire’s retail and wholesale business.
Emerging markets and OSS
    Instituto Costarricense de Electricidad (ICE), Costa Rica’s national service provider of telecommunications, will implement Amdocs OSS 7.5 to support ICE’s OSS needs, including planning, inventory and discovery, provisioning and activation, trouble ticketing, service fulfillment and service impact analysis.
 
    A mobile operator in Asia-Pacific selected Amdocs OSS to support its GSM network.
 
    Amdocs signed a new wireless customer in Africa for a pre-paid billing solution.
Additionally, in North America, Amdocs won a significant new Amdocs Interactive project to support a wireless customer’s on-portal digital content storefront including content management, commerce, discovery, and delivery as well as a billing consolidation project for an existing wireline customer.
Free cash flow was $62 million for the quarter, comprised of cash flow from operations of $80 million less approximately $18 million in net capital expenditures and other. Included in the calculation of second quarter free cash flow was $52 million in annual employee bonus payments.
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.37 billion at the end of the second quarter of fiscal 2009.
Financial Outlook
Amdocs expects that revenue for the third quarter of fiscal 2009 will be approximately $670-$690 million. Amdocs expects diluted earnings per share on a non-GAAP basis for the third quarter to be $0.46-$0.50, excluding acquisition-related costs and approximately $0.04-$0.05

 


 

per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the third quarter will be $0.33-$0.38.
Amdocs will host a conference call on April 22, 2009 at 5 p.m. Eastern Time to discuss the Company’s second quarter results. The call will be carried live on the Internet via www.InvestorCalendar.com and the Amdocs website, www.amdocs.com.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income. These non-GAAP measures exclude the following items:
    amortization of purchased intangible assets;
 
    in-process research and development write-off;
 
    restructuring charges;
 
    equity-based compensation expense; and
 
    tax effects related to the above.
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.
Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income, when shown in conjunction with the corresponding GAAP measures, provides useful

 


 

information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.
For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets, in-process research and development write-off, restructuring charges, equity-based compensation expense, and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments.
Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
About Amdocs
Amdocs is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and the intentional customer experienceTM – at every point of service.  Amdocs provides solutions that deliver customer experience excellence, combining the software, service and expertise to help its customers execute their strategies and achieve service, operational and financial excellence. A global company with revenue of $3.16 billion in fiscal 2008, Amdocs has more than 17,000

 


 

employees and serves customers in more than 50 countries around the world. For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company’s filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2008 filed on December 8, 2008 and in our quarterly 6-K furnished on February 9, 2009.
Contact:
Thomas G. O’Brien
Treasurer and Vice President of Investor Relations
Amdocs Limited
314-212-8328
E-mail: dox_info@amdocs.com

 


 

AMDOCS LIMITED
Consolidated Statements of Income
(in thousands, except per share data)
                                 
    Three months ended     Six months ended  
    March 31,     March 31,  
    2009     2008     2009     2008  
Revenue:
                               
License
  $ 37,203     $ 32,109     $ 81,804     $ 58,326  
Service
    673,881       742,172       1,383,119       1,458,205  
 
                       
 
    711,084       774,281       1,464,923       1,516,531  
Operating expenses:
                               
Cost of license
    569       938       1,560       1,712  
Cost of service
    455,997       493,956       940,048       964,697  
Research and development
    52,750       56,088       108,979       112,103  
Selling, general and administrative
    84,308       98,666       174,573       196,331  
 
Amortization of purchased intangible assets
    21,501       21,753       41,755       43,506  
Restructuring charges and in-process research and development (1)
                20,780        
 
                       
 
    615,125       671,401       1,287,695       1,318,349  
 
                       
Operating income
    95,959       102,880       177,228       198,182  
 
                               
Interest (expense) income and other, net
    (5,763 )     8,822       (3,528 )     17,638  
 
                       
Income before income taxes
    90,196       111,702       173,700       215,820  
 
                               
Income taxes
    9,566       11,843       18,823       20,297  
 
                       
Net income
  $ 80,630     $ 99,859     $ 154,877     $ 195,523  
 
                       
Basic earnings per share
  $ 0.40     $ 0.48     $ 0.76     $ 0.94  
 
                       
Diluted earnings per share (2)
  $ 0.39     $ 0.46     $ 0.74     $ 0.89  
 
                       
Basic weighted average number of shares outstanding
    202,671       206,759       202,561       207,437  
 
                       
Diluted weighted average number of shares outstanding
    209,755       219,786       211,013       220,912  
 
                       
 
(1)   Restructuring charges and in-process research and development for the six months ended March 31, 2009 includes restructuring charges of $15,140, and in-process research and development of $5,640.
 
(2)   To reflect the impact of assumed conversion of the convertible notes, $622 and $1,486 representing interest expense and amortization of issuance costs, were added back to net income for the three and six months ended March 31, 2009, respectively, and $985 and $1,970 were added back to net income for the three and six months ended March 31, 2008, respectively, for the purpose of computing diluted earnings per share.

 


 

AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
                                 
    Three months ended   Six months ended
    March 31,   March 31,
    2009   2008   2009   2008
Revenue
  $ 711,084     $ 774,281     $ 1,464,923     $ 1,516,531  
 
                               
Non-GAAP operating income
    127,977       138,046       263,697       269,317  
 
                               
Non-GAAP net income
    104,875       126,647       221,125       249,937  
 
Non-GAAP diluted earnings per share (1)
  $ 0.50     $ 0.58     $ 1.05     $ 1.14  
 
                               
Diluted weighted average number of shares outstanding
    209,755       219,786       211,013       220,912  
 
(1)   To reflect the impact of assumed conversion of the convertible notes, $622 and $1,486 representing interest expense and amortization of issuance costs, were added back to net income for the three and six months ended March 31, 2009, respectively, and $985 and $1,970 were added back to net income for the three and six months ended March 31, 2008, respectively, for the purpose of computing diluted earnings per share.

 


 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                         
    Three months ended
    March 31, 2009
            Reconciliation items    
            Amortization            
            of purchased   Equity based        
            intangible   compensation        
    GAAP   assets   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                       
Cost of license
  $ 569     $     $     $     $ 569  
Cost of service
    455,997             (4,950 )           451,047  
Research and development
    52,750             (977 )           51,773  
Selling, general and administrative
    84,308             (4,590 )           79,718  
Amortization of purchased intangible assets
    21,501       (21,501 )                  
     
Total operating expenses
    615,125       (21,501 )     (10,517 )           583,107  
     
 
                                       
     
Operating income
    95,959       21,501       10,517             127,977  
     
 
                                       
     
Income taxes
    9,566                   7,773       17,339  
     
 
                                       
     
Net income
  $ 80,630     $ 21,501     $ 10,517     $ (7,773 )   $ 104,875  
     
                                         
    Three months ended
    March 31, 2008
            Reconciliation items    
            Amortization            
            of purchased   Equity based        
            intangible   compensation        
    GAAP   assets   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                       
Cost of license
  $ 938     $     $     $     $ 938  
Cost of service
    493,956             (5,431 )           488,525  
Research and development
    56,088             (1,146 )           54,942  
Selling, general and administrative
    98,666             (6,836 )           91,830  
Amortization of purchased intangible assets
    21,753       (21,753 )                  
     
Total operating expenses
    671,401       (21,753 )     (13,413 )           636,235  
     
 
                                       
     
Operating income
    102,880       21,753       13,413             138,046  
     
 
                                       
     
Income taxes
    11,843                   8,378       20,221  
     
 
                                       
     
Net income
  $ 99,859     $ 21,753     $ 13,413     $ (8,378 )   $ 126,647  
     

 


 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                                 
    Six months ended
    March 31, 2009
            Reconciliation items    
            Amortization   Restructuring            
            of purchased   charges and in-   Equity based        
            intangible   process research   compensation        
    GAAP   assets   and development   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                               
Cost of license
  $ 1,560     $     $     $     $     $ 1,560  
Cost of service
    940,048                   (10,661 )           929,387  
Research and development
    108,979                   (2,039 )           106,940  
Selling, general and administrative
    174,573                   (11,234 )           163,339  
Amortization of purchased intangible assets
    41,755       (41,755 )                        
Restructuring charges and in-process research and development
    20,780             (20,780 )                  
     
Total operating expenses
    1,287,695       (41,755 )     (20,780 )     (23,934 )           1,201,226  
     
 
                                               
     
Operating income
    177,228       41,755       20,780       23,934             263,697  
     
 
                                               
     
Income taxes
    18,823                         20,221       39,044  
     
 
                                               
     
Net income
  $ 154,877     $ 41,755     $ 20,780     $ 23,934     $ (20,221 )   $ 221,125  
     
                                         
    Six months ended
    March 31, 2008
            Reconciliation items    
            Amortization            
            of purchased   Equity based        
            intangible   compensation        
    GAAP   assets   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                       
Cost of license
  $ 1,712     $     $     $     $ 1,712  
Cost of service
    964,697             (11,713 )           952,984  
Research and development
    112,103             (2,522 )           109,581  
Selling, general and administrative
    196,331             (13,394 )           182,937  
Amortization of purchased intangible assets
    43,506       (43,506 )                  
     
Total operating expenses
    1,318,349       (43,506 )     (27,629 )           1,247,214  
     
 
                                       
     
Operating income
    198,182       43,506       27,629             269,317  
     
 
                                       
     
Income taxes
    20,297                   16,721       37,018  
     
 
                                       
     
Net income
  $ 195,523     $ 43,506     $ 27,629     $ (16,721 )   $ 249,937  
     

 


 

AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
                 
    As of  
    March 31,     September 30,  
    2009     2008  
ASSETS
               
 
               
Current assets
               
Cash, cash equivalents and short-term interest-bearing investments
  $ 1,334,856     $ 1,244,378  
Accounts receivable, net, including unbilled of $42,323 and $48,264 respectively
    506,685       573,764  
Deferred income taxes and taxes receivable
    98,843       84,515  
Prepaid expenses and other current assets
    96,371       102,930  
 
           
Total current assets
    2,036,755       2,005,587  
 
               
Equipment and leasehold improvements, net
    292,261       317,081  
Goodwill and other intangible assets, net
    1,809,335       1,796,922  
Other noncurrent assets
    426,361       459,473  
 
           
Total assets
  $ 4,564,712     $ 4,579,063  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
 
               
Current liabilities
               
Accounts payable and accruals
  $ 525,917     $ 600,285  
Short-term portion of financing arrangements
    3,660       1,660  
Deferred revenue
    155,553       197,851  
Deferred income taxes and taxes payable
    31,265       30,228  
 
           
Total current liabilities
    716,395       830,024  
 
               
0.50% Convertible notes
    1,020       450,000  
Long-term loan
    450,000        
Noncurrent liabilities and other
    439,651       493,848  
Shareholders’ equity
    2,957,646       2,805,191  
 
           
Total liabilities and shareholders’ equity
  $ 4,564,712     $ 4,579,063  
 
           

 


 

AMDOCS LIMITED
Consolidated Statements of Cash Flows
(in thousands)
                 
    Six months ended March 31,  
    2009     2008  
Cash Flow from Operating Activities:
               
Net income
  $ 154,877     $ 195,523  
Reconciliation of net income to net cash provided by operating activities:
               
Depreciation and amortization
    98,491       94,202  
In-process research and development
    5,640        
Loss on sale of equipment
          65  
Equity-based compensation expense
    23,934       27,629  
Deferred income taxes
    11,258       (4,255 )
Gain on repurchase of convertible notes
    (2,185 )      
Excess tax benefit from equity-based compensation
    (2 )     (87 )
Loss from short-term interest-bearing investments
    4,991       1,755  
Net changes in operating assets and liabilities, net of amounts acquired:
               
Accounts receivable
    67,244       (125,634 )
Prepaid expenses and other current assets
    5,905       (4,624 )
Other noncurrent assets
    21,725       (24,963 )
Accounts payable, accrued expenses and accrued personnel
    (61,315 )     (11,079 )
Deferred revenue
    (49,005 )     30,817  
Income taxes payable
    (15,932 )     (4,694 )
Noncurrent liabilities and other
    (44,027 )     15,790  
 
           
Net cash provided by operating activities
    221,599       190,445  
 
           
 
               
Cash Flow from Investing Activities:
               
Proceeds from sale of equipment and leasehold improvements
    340       673  
Payments for purchase of equipment and leasehold improvements
    (47,818 )     (69,126 )
Proceeds from sale of short-term interest-bearing investments
    323,234       360,297  
Purchase of short-term interest-bearing investments
    (376,579 )     (301,260 )
Net cash paid for acquisition
    (61,855 )     (9,242 )
 
           
Net cash used in investing activities
    (162,678 )     (18,658 )
 
           
 
               
Cash Flow from Financing Activities:
               
Borrowing under long-term financing arrangements
    450,000        
Redemption of convertible notes
    (330,780 )      
Repurchase of convertible notes
    (116,015 )      
Repurchase of shares
    (20,014 )     (122,441 )
Proceeds from employee stock options exercised
    1,797       15,736  
Borrowing under short-term financing arrangements
    540        
Payments under capital lease financing arrangements
    (950 )      
Excess tax benefit from equity-based compensation
    2       87  
 
           
Net cash used in financing activities
    (15,420 )     (106,618 )
 
           
 
               
Net increase in cash and cash equivalents
    43,501       65,169  
Cash and cash equivalents at beginning of period
    718,850       615,501  
 
           
Cash and cash equivalents at end of period
  $ 762,351     $ 680,670  
 
           

 


 

AMDOCS LIMITED
Supplementary Information
(in millions)
                                         
    Three months ended  
            December 31,     September 30,     June 30,     March 31,  
    March 31, 2009     2008     2008     2008     2008  
North America
  $ 539.8     $ 561.6     $ 558.7     $ 570.5     $ 541.5  
Europe
    105.0       111.4       150.9       133.0       135.8  
Rest of World
    66.3       80.8       115.7       116.8       97.0  
 
                             
Total Revenue
  $ 711.1     $ 753.8     $ 825.3     $ 820.3     $ 774.3  
 
                             
                                         
    Three months ended  
            December 31,     September 30,     June 30,     March 31,  
    March 31, 2009     2008     2008     2008     2008  
Customer Experience
                                       
Systems
  $ 668.0     $ 701.0     $ 756.5     $ 756.9     $ 708.2  
Directory
    43.1       52.8       68.8       63.4       66.1  
 
                             
Total Revenue
  $ 711.1     $ 753.8     $ 825.3     $ 820.3     $ 774.3  
 
                             
                                         
    As of  
            December 31,     September 30,     June 30,     March 31,  
    March 31, 2009     2008     2008     2008     2008  
12-Month Backlog
  $ 2,370     $ 2,400     $ 2,420     $ 2,420     $ 2,360  
 
                             
# # #